Doxepin combats itch primarily by blocking histamine receptors, specifically H1 receptors. This action directly interferes with the histamine-mediated pathway responsible for triggering the sensation of itch.
Beyond histamine, doxepin also interacts with other neurotransmitters in the central nervous system. It inhibits the reuptake of norepinephrine and serotonin. This dual action modulates the transmission of itch signals within the spinal cord and brain, providing further itch relief. The altered neurotransmitter levels influence how the brain processes and perceives itch sensations, effectively diminishing the intensity of the feeling.
The exact contribution of each mechanism (histamine receptor blockade vs. neurotransmitter reuptake inhibition) to doxepin’s antipruritic effect is still under investigation. However, the combined effects on both peripheral and central pathways offer a multi-pronged approach to itch management.
| H1 receptor antagonism | Direct inhibition of histamine-induced itch |
| Norepinephrine and serotonin reuptake inhibition | Modulation of itch signal transmission in the central nervous system |
It’s important to note that individual responses to doxepin vary. While the mechanisms described above explain its efficacy, the specific experience of itch relief depends on numerous factors including the underlying cause of pruritus, individual patient physiology, and the prescribed dosage.
